Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
Accenture
Express Scripts
McKinsey
Moodys
Novartis
Deloitte
McKesson
Covington
Dow

Generated: February 22, 2018

DrugPatentWatch Database Preview

VANCOMYCIN HYDROCHLORIDE IN PLASTIC CONTAINER Drug Profile

« Back to Dashboard

When do Vancomycin Hydrochloride In Plastic Container patents expire, and what generic alternatives are available?

Vancomycin Hydrochloride In Plastic Container is a drug marketed by Samson Medcl and is included in one NDA.

The generic ingredient in VANCOMYCIN HYDROCHLORIDE IN PLASTIC CONTAINER is vancomycin hydrochloride. There are twenty-two drug master file entries for this compound. Twenty-seven suppliers are listed for this compound. Additional details are available on the vancomycin hydrochloride profile page.
Summary for VANCOMYCIN HYDROCHLORIDE IN PLASTIC CONTAINER
Drug patent expirations by year for VANCOMYCIN HYDROCHLORIDE IN PLASTIC CONTAINER
Pharmacology for VANCOMYCIN HYDROCHLORIDE IN PLASTIC CONTAINER
Medical Subject Heading (MeSH) Categories for VANCOMYCIN HYDROCHLORIDE IN PLASTIC CONTAINER

US Patents and Regulatory Information for VANCOMYCIN HYDROCHLORIDE IN PLASTIC CONTAINER

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Samson Medcl VANCOMYCIN HYDROCHLORIDE IN PLASTIC CONTAINER vancomycin hydrochloride POWDER;IV (INFUSION) 091532-001 Jan 6, 2016 RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Express Scripts
Julphar
Moodys
Colorcon
Medtronic
Federal Trade Commission
Deloitte
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot